Locke, F. L., Munoz, J. L., Tees, M. T., Lekakis, L. J., Vos, S. D., Nath, R., Stevens, D. A., Malik, S. A., Shouse, G. P., Hamadani, M., Oluwole, O. O., Perales, M., Miklos, D. B., Fisher, P. W., Feng, A., Navale, L., Gall, J. B. L., Neelapu, S. S. (2025). Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01933